Table S5 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection

Table S5 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection

<p>Table S5: Associations between driver mutations in BC and common risk factors</p>

Сохранить в:

Библиографические подробности
Главный автор:	Nina Rao (15321199) (author)
Другие авторы:	Gabriel J. Starrett (16624138) (author), Mary L. Piaskowski (17079483) (author), Kelly E. Butler (17079486) (author), Yelena Golubeva (17079489) (author), Wusheng Yan (17079492) (author), Scott M. Lawrence (17079495) (author), Michael Dean (14946283) (author), Montserrat Garcia-Closas (15035106) (author), Dalsu Baris (15321208) (author), Alison Johnson (15035103) (author), Molly Schwenn (15321211) (author), Nuria Malats (14943841) (author), Francisco X. Real (15337922) (author), Manolis Kogevinas (13368975) (author), Nathaniel Rothman (15321220) (author), Debra T. Silverman (15321223) (author), Lars Dyrskjøt (15054430) (author), Christopher B. Buck (17079498) (author), Stella Koutros (15035094) (author), Ludmila Prokunina-Olsson (15021962) (author)
Опубликовано:	2025
Предметы:	Cancer Cancer Biology Cancer Detection and Diagnosis Epidemiology Biomarkers Genetic biomarkers Genitourinary Cancers Bladder cancer Methodology and Modeling Viral Oncogenesis DNA tumor viruses
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы

Table S1 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
по: Nina Rao (15321199)
Опубликовано: (2025)

Table S2 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
по: Nina Rao (15321199)
Опубликовано: (2025)

Table S3 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
по: Nina Rao (15321199)
Опубликовано: (2025)

Table S4 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
по: Nina Rao (15321199)
Опубликовано: (2025)

Table S6 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
по: Nina Rao (15321199)
Опубликовано: (2025)

Table S7 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
по: Nina Rao (15321199)
Опубликовано: (2025)

Figure 1 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
по: Alba L. Combita (22677298)
Опубликовано: (2025)

Figure 2 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
по: Alba L. Combita (22677298)
Опубликовано: (2025)

Figure 3 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
по: Alba L. Combita (22677298)
Опубликовано: (2025)

Figure 4 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
по: Alba L. Combita (22677298)
Опубликовано: (2025)

Figure 5 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
по: Alba L. Combita (22677298)
Опубликовано: (2025)

Table 1 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
по: Alba L. Combita (22677298)
Опубликовано: (2025)

Table 1 from Addressing Common Misuses and Pitfalls of <i>P</i> values in Biomedical Research
по: Ming Wang (8809334)
Опубликовано: (2025)

Supplementary Data from Genetic Modulation of <i>BET1L</i> Confers Colorectal Cancer Susceptibility by Reducing miRNA Binding and m<sup>6</sup>A Modification
по: Shuwei Li (16437116)
Опубликовано: (2025)

Supplementary Tables from The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer
по: Weisi Liu (14963321)
Опубликовано: (2025)

Supplementary Video from The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer
по: Weisi Liu (14963321)
Опубликовано: (2025)

Supplementary Data from Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics
по: Yuan Chun Ding (16721349)
Опубликовано: (2025)

Supplementary Data from Genome-Wide Analysis of Rare Haplotypes Associated with Breast Cancer Risk
по: Fan Wang (14963418)
Опубликовано: (2025)

Supplementary Table S1 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
по: Athanasios Bikas (16006076)
Опубликовано: (2025)

Figure 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
по: Erwei Zeng (14958443)
Опубликовано: (2025)

Figure 2 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
по: Erwei Zeng (14958443)
Опубликовано: (2025)

Figure 3 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
по: Erwei Zeng (14958443)
Опубликовано: (2025)

Figure 4 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
по: Erwei Zeng (14958443)
Опубликовано: (2025)

Table 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
по: Erwei Zeng (14958443)
Опубликовано: (2025)

Supplementary Table S1 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
по: Emil Christensen (15054394)
Опубликовано: (2025)

Supplementary Table S2 from Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
по: Emil Christensen (15054394)
Опубликовано: (2025)

Supplementary Tables S1-S5 from Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era
по: Josephine K. Dermawan (17079555)
Опубликовано: (2025)

Characterization of a Novel Porcine Circovirus Type 2a Sequence and Anti-Viral Evaluation of Matrine and Sanguinarine Combined with Network Pharmacology and Molecular Docking
по: WENTING Qiao (22587494)
Опубликовано: (2025)

Supplementary Data 2 from Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study
по: Ismael Fernández-Miranda (15051932)
Опубликовано: (2025)

Supplementary Tables S1-S12 from Gene-Level Germline Contributions to Clinical Risk of Recurrence Scores in Black and White Patients with Breast Cancer
по: Achal Patel (5853731)
Опубликовано: (2025)

Figure S1 from Estimation of Neutral Mutation Rates and Quantification of Somatic Variant Selection Using cancereffectsizeR
по: Jeffrey D. Mandell (14963909)
Опубликовано: (2025)

Table S1-S8 from Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
по: Ruiyun Zhang (17142498)
Опубликовано: (2025)

Supplementary Figure S1 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
по: Sarita Paudel (15047430)
Опубликовано: (2025)

Supplementary Figure S2 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
по: Sarita Paudel (15047430)
Опубликовано: (2025)

Supplementary Figure S3 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
по: Sarita Paudel (15047430)
Опубликовано: (2025)

Supplementary Figure S4 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
по: Sarita Paudel (15047430)
Опубликовано: (2025)

Supplementary Figure S5 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
по: Sarita Paudel (15047430)
Опубликовано: (2025)

Supplementary Figure S6 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
по: Sarita Paudel (15047430)
Опубликовано: (2025)

Supplementary Figure S1 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
по: Leon J. Wils (15055780)
Опубликовано: (2025)

Supplementary Figure S10 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
по: Leon J. Wils (15055780)
Опубликовано: (2025)

Cannot write session to /tmp/vufind_sessions/sess_mfv2ght18h4sdhs8g6c62nqsoi